APA
Kuhen K. L., Chatterjee A. K., Rottmann M., Gagaring K., Borboa R., Buenviaje J., Chen Z., Francek C., Wu T., Nagle A., Barnes S. W., Plouffe D., Lee M. C. S., Fidock D. A., Graumans W., van de Vegte-Bolmer M., van Gemert G. J., Wirjanata G., Sebayang B., Marfurt J., Russell B., Suwanarusk R., Price R. N., Nosten F., Tungtaeng A., Gettayacamin M., Sattabongkot J., Taylor J., Walker J. R., Tully D., Patra K. P., Flannery E. L., Vinetz J. M., Renia L., Sauerwein R. W., Winzeler E. A., Glynne R. J. & Diagana T. T. (20150909). KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. : Antimicrobial agents and chemotherapy.
Chicago
Kuhen Kelli L, Chatterjee Arnab K, Rottmann Matthias, Gagaring Kerstin, Borboa Rachel, Buenviaje Jennifer, Chen Zhong, Francek Carolyn, Wu Tao, Nagle Advait, Barnes S Whitney, Plouffe David, Lee Marcus C S, Fidock David A, Graumans Wouter, van de Vegte-Bolmer Marga, van Gemert Geert J, Wirjanata Grennady, Sebayang Boni, Marfurt Jutta, Russell Bruce, Suwanarusk Rossarin, Price Ric N, Nosten Francois, Tungtaeng Anchalee, Gettayacamin Montip, Sattabongkot Jetsumon, Taylor Jennifer, Walker John R, Tully David, Patra Kailash P, Flannery Erika L, Vinetz Joseph M, Renia Laurent, Sauerwein Robert W, Winzeler Elizabeth A, Glynne Richard J and Diagana Thierry T. 20150909. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. : Antimicrobial agents and chemotherapy.
Harvard
Kuhen K. L., Chatterjee A. K., Rottmann M., Gagaring K., Borboa R., Buenviaje J., Chen Z., Francek C., Wu T., Nagle A., Barnes S. W., Plouffe D., Lee M. C. S., Fidock D. A., Graumans W., van de Vegte-Bolmer M., van Gemert G. J., Wirjanata G., Sebayang B., Marfurt J., Russell B., Suwanarusk R., Price R. N., Nosten F., Tungtaeng A., Gettayacamin M., Sattabongkot J., Taylor J., Walker J. R., Tully D., Patra K. P., Flannery E. L., Vinetz J. M., Renia L., Sauerwein R. W., Winzeler E. A., Glynne R. J. and Diagana T. T. (20150909). KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. : Antimicrobial agents and chemotherapy.
MLA
Kuhen Kelli L, Chatterjee Arnab K, Rottmann Matthias, Gagaring Kerstin, Borboa Rachel, Buenviaje Jennifer, Chen Zhong, Francek Carolyn, Wu Tao, Nagle Advait, Barnes S Whitney, Plouffe David, Lee Marcus C S, Fidock David A, Graumans Wouter, van de Vegte-Bolmer Marga, van Gemert Geert J, Wirjanata Grennady, Sebayang Boni, Marfurt Jutta, Russell Bruce, Suwanarusk Rossarin, Price Ric N, Nosten Francois, Tungtaeng Anchalee, Gettayacamin Montip, Sattabongkot Jetsumon, Taylor Jennifer, Walker John R, Tully David, Patra Kailash P, Flannery Erika L, Vinetz Joseph M, Renia Laurent, Sauerwein Robert W, Winzeler Elizabeth A, Glynne Richard J and Diagana Thierry T. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. : Antimicrobial agents and chemotherapy. 20150909.